Literature DB >> 19358299

Iron: The fifth horseman of the apocalypse?

Thomas G DeLoughery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19358299     DOI： 10.1002/ajh.21413

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes.

Authors:  Hussam Ghoti; Eitan Fibach; Drorit Merkel; Galit Perez-Avraham; Sigal Grisariu; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  Myelodysplastic syndromes--many new drugs, little therapeutic progress.

Authors:  Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2010-09-22       Impact factor: 7.616

Review 3.  The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate.

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2011-06       Impact factor: 3.952

4.  A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS.

Authors:  Aristoteles Giagounidis; Susanna Leto di Priolo; Susanne Ille; Pierre Fenaux
Journal:  Ann Hematol       Date:  2011-02-16       Impact factor: 3.673
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.